SRDX - SurModics - Biotech IPO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRDX - SurModics - Biotech IPO

SRDX 27.44

+1.0%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: lindend who wrote (11)	6/30/1998 10:04:00 PM
From: Donald carlson	Read Replies (1) of 84

Kinnard earnings revision. Kinnards the only company that seems to track SRDX revised 2nd qtr estimates upward today. Revenue up from 2.4 to 2.6 and earnings up from 4 to 6 cents. 98 EPS to 19 cents. IMO kinnards analyst is conservative. There is 2-3 cents of new 3rd qtr interest fom the $15m offering that doesn't seem to be included. Looks like a positive qtr.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next